|
|
| Attention Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
Your results on : Equity | Company Profile | Detailed Quotes |
|
|
|
|
|
|
|
|
|
|
|
| Stock Price Details |
|
Chart |
|
| Last Price |
0.53 |
|
| Change |
0.04 (8.16%) |
|
| Best Buy |
0(x0) |
|
| Best Sell |
0(x0) |
|
| Today's Range |
0.53
- 0.53 |
|
| 52-Week Range |
0.44
- 1.55 |
|
|
|
1 Day
| 5 Day
| 3 Month
| 1 Year
| 5 Year
|
|
|
|
| News |
|
Corporate Details |
|
|
|
| Incorporation Year : 2015 |
|
| Chairman : Rajnishkumar Surendra Prasad Singh |
|
| Ownership Group : Indian Private |
|
| Sector : MAN |
|
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Registered Office |
|
Rajnish Wellness Ltd Bldg No 3 Navijivan Comm Socie, 6 Th Floor Office No 10L, , Maharashtra-400008 |
|
Phone:91-22-23065555 Fax: |
|
| E-Mail : info@rajnishwellness.com |
|
| URL : http://www.rajnishwellness.com |
|
|
|
| Investor Returns |
|
| |
|
Date |
|
Price (Rs) |
|
Returns (%) |
|
|
| 1Week |
24-Dec-2025 |
0.55 |
-10.91 |
|
| 1Month |
01-Dec-2025 |
0.73 |
-32.88 |
|
| 3Month |
30-Sep-2025 |
0.93 |
-47.31 |
|
| 6Month |
30-Jun-2025 |
0.86 |
-43.02 |
|
| 1Year |
31-Dec-2024 |
1.46 |
-66.44 |
|
|
|
|
| Mutual Funds Holding |
|
| No Data Found |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
|
Last Price(Rs) |
|
Change(%) |
|
52Week High(Rs) |
|
52Week Low(Rs) |
|
Market Cap(Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,720.40 |
0.04 |
1,910.00 |
1,547.25 |
4,12,625.63 |
|
| Cipla Ltd |
1,500.10 |
-0.71 |
1,672.20 |
1,310.05 |
1,22,046.15 |
|
| Dr Reddys Laboratories Ltd |
1,253.60 |
-1.37 |
1,404.60 |
1,025.90 |
1,06,085.69 |
|
| Lupin Ltd |
2,103.30 |
-0.41 |
2,403.45 |
1,774.00 |
96,475.91 |
|
| Zydus Lifesciences Ltd |
914.50 |
-0.02 |
1,059.00 |
797.05 |
92,035.19 |
|
|
|
|
|
|
|
| |
|
|
| |
| X |
| Filing complaints on SCORES |
| Easy & Quick |
| |
| › |
Register on SCORES Portal |
› |
Mandatory details for filing complaints on SCORES
| Name |
PAN |
Address |
Mobile No. |
Email ID |
|
| › |
Benefits: |
| |
|
|
|